Across TCGA pan-cancer cohorts, C6orf99 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated C6orf99 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher C6orf99 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated C6orf99 expression acts as an unfavorable survival marker.

COAD are the cancer types where C6orf99 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.160	0.693	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: C6orf99 tumor-vs-normal RNA expression · all C6orf99 data types